GlassScriptPhysician profile
Byron C Edwards
NPI 1902887193
$5,901.91
in general payments reported to CMS, 2019-2025
20 companies · $1,133 in 2025
The $1,133 reported for 2025 was more than what 85% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,050 · 2022: $1,149 · 2023: $1,259 · 2024: $1,311 · 2025: $1,133.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,469 · Education: $234.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,469.01 |
| Education | $234.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,927.50 | 2021-2025 | |
| Sun Pharmaceutical Industries INC. | $799.01 | 2021-2025 | Ilumya, Winlevi, Absorica Ld |
| Galderma Laboratories, L.P. | $596.31 | 2021-2025 | Nemluvio, Aklief |
| Janssen Biotech, INC. | $368.03 | 2021-2025 | Tremfya, Stelara, Simponi |
| Novartis Pharmaceuticals Corporation | $315.33 | 2022-2025 | |
| Ucb, INC. | $242.59 | 2021-2025 | Bimzelx, Cimzia |
| Pfizer INC. | $230.58 | 2021-2025 | |
| Genzyme Corporation | $214.47 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $213.16 | 2022-2024 | Sotyktu |
| Lilly USA, LLC | $176.51 | 2021-2025 | Ebglyss, Taltz, Olumiant |
| Regeneron Healthcare Solutions, INC. | $157.26 | 2022-2025 | Dupixent |
| Leo Pharma INC. | $135.70 | 2022-2024 | Adbry |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $119.89 | 2021-2025 | Cabtreo |
| Sanofi-Aventis U.S. LLC | $99.99 | 2022 | |
| Vyne Pharmaceuticals INC. | $69.48 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $59.45 | 2021-2022 | |
| Arcutis Biotherapeutics, INC. | $49.87 | 2023-2025 | Zoryve |
| Dermavant Sciences, INC. | $48.24 | 2023-2024 | Vtama |
| Organon LLC | $39.52 | 2023-2025 | Vtama, Nexplanon |
| Amgen INC. | $39.02 | 2023 | Otezla |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Byron Edwards listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.